Health
FDA schedules meeting to discuss emergency use authorization of COVID-19 vaccine from Pfizer – News-Medical.Net
The U.S. Food and Drug Administration has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 10 to discuss…
Reviewed by Emily Henderson, B.Sc.Nov 23 2020
The U.S. Food and Drug Administration has request for emergency use authorization a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 10 to discuss the request for emergency use authorization (EUA) of a COVID-19 vaccine from Pfizer, Inc. in partnership with BioNTech Manufacturing GmbH.
The FDA recognizes that transparency and dialogue are critical for the public to have confidence in COVID-19 vaccines. I want…
-
Noosa News24 hours agoHow a 3D printed aorta helped surgeons replace a ‘ticking time bomb’ inside a man’s chest
-
Noosa News20 hours agoEnsure voices are heard – Proctor
-
Noosa News16 hours agoMajor crash on Gateway Motorway snarls morning commute
-
Noosa News22 hours agoCity of Moreton Bay claims homeless people consented to having camps thrown away